Continued Process Verification (CPV): Maintaining the Validated State in Medical Cannabis Manufacturing

What is Continued Process Verification?

Continued Process Verification is the ongoing collection, review and interpretation of process and product data during routine manufacturing. Its purpose is to confirm that the validated state is maintained and that the process continues to produce product meeting predefined quality requirements.

CPV is part of the validation lifecycle. It does not replace Process Performance Qualification (PPQ), and it is not simply an annual report. It is the routine evidence that a process remains understood, controlled and capable after validation batches have been completed.

In practice, CPV may include review of critical process parameters, critical quality attributes, environmental data, deviations, batch trends, laboratory results, equipment performance, alarms, yields, hold times, rework, complaints and change controls.

Why CPV matters in medical cannabis

Medical cannabis manufacturing can be vulnerable to variation. Plant material is biologically variable, process histories may be limited, and many companies are still maturing from wellness, agricultural or pilot-scale operations into pharmaceutical-grade production. CPV helps detect whether a process remains stable as batches, equipment, operators, raw materials or operating conditions change.

For cannabis products, CPV can support control of:

• cannabinoid assay and product strength;
• moisture content and water activity;
• microbial quality;
• residual solvent levels;
• terpene or impurity profile where relevant;
• fill volume, capsule weight or dose uniformity;
• yield, recovery and batch consistency;
• environmental conditions and contamination risk;
• process drift after changes or scale-up.

Without CPV, a company may complete validation and then slowly lose process control without recognising it until a deviation, complaint, failed batch or inspection finding occurs.

PPQ vs CPV

Process Performance Qualification demonstrates that the process can perform under defined conditions during qualification batches. Continued Process Verification confirms that the process continues to perform during routine manufacturing.

A strong validation programme treats PPQ as the start of routine control, not the end of validation thinking.

What should be monitored?

The CPV plan should identify which parameters and attributes are meaningful indicators of process control. It should not include every possible data point simply because the data exists. The best CPV programmes are risk-based, focused and linked to process understanding.

Typical CPV inputs may include:

• critical process parameter trends;
• critical quality attribute results;
• in-process control data;
• environmental monitoring results;
• yield and recovery data;
• equipment alarms and interventions;
• cleaning verification or validation data;
• laboratory out-of-trend observations;
• deviations and repeat events;
• complaints and product quality signals;
• change control impact after implementation.

CQAs, CPPs and trend review

CPV should link back to the process validation rationale. If a parameter was considered critical during validation, it should usually be monitored during routine operation unless there is a documented reason not to do so.

For example, if drying temperature, drying time and relative humidity affect moisture content and microbial risk, then those parameters and related product results should be trended. If extraction temperature, pressure or solvent ratio affect yield or impurity profile, they should be monitored with appropriate limits and review frequency.

Trend review should be capable of identifying drift before failure. A batch may remain within specification while showing a directional trend towards a limit. CPV should help the quality system recognise these early signals and act before formal non-conformance occurs.

Statistical tools can help, but CPV should not become a purely statistical exercise. The interpretation must be scientifically meaningful and connected to product and process knowledge.

PQR/APQR and management review

Product Quality Review or Annual Product Quality Review is a natural home for CPV conclusions. CPV data can feed into annual product review, management review, validation review and quality planning. The objective is to convert routine data into quality intelligence.

A PQR/APQR may consider:

• batch history and production volumes;
• critical quality attributes and specification results;
• process parameter trends;
• deviations, CAPAs and complaints;
• changes implemented during the review period;
• stability data;
• supplier or raw material issues;
• validation status and revalidation needs;
• recommendations for improvement.

For growing cannabis manufacturers, this is especially valuable because it helps move the company from reactive batch release into proactive quality management.

Integration with deviations, CAPA and change control

CPV should not sit outside the quality system. It should interact directly with deviations, CAPA, change control, complaints, periodic review and validation maintenance.

When CPV identifies an adverse trend, the company should decide whether the signal requires monitoring, investigation, corrective action, preventive action, process improvement or formal change control. If a change is implemented, CPV should then confirm whether the change achieved the intended effect without introducing new risks.

This creates a continuous feedback loop:

• process data identifies a signal;
• quality system evaluates the signal;
• action is taken where justified;
• change or CAPA is implemented;
• CPV confirms whether control improved.

Medical cannabis examples

Dried flower process

For dried flower, CPV may trend drying conditions, moisture content, water activity, microbial results, batch yield, trimming losses, storage conditions and complaints related to product appearance or consistency. Trends may reveal seasonal variability, loading-pattern issues or drift in drying performance.

Extract manufacturing

For extracts, CPV may trend extraction yield, solvent recovery, residual solvents, cannabinoid concentration, impurity profile, filtration performance and batch-to-batch potency variability. The review may identify equipment fouling, raw material variation or scale-up challenges.

Packaging and labelling

For packaging, CPV may include fill quantity, label reconciliation, line clearance observations, packaging defects, complaints, temperature excursions and GDP-related issues. Where products are dose-sensitive, packaging and labelling controls can be critical to patient safety.

Common mistakes

• Stopping validation thinking after PPQ. Validation must be maintained through lifecycle review.
• Collecting too much data with no interpretation. CPV requires meaningful review, not just spreadsheets.
• Trending only final product results. Process parameters and in-process controls are often more useful early indicators.
• Failing to define alert or action expectations. Teams need to know what happens when a trend changes.
• No link to CAPA or change control. CPV findings should trigger improvement where justified.
• Ignoring raw material variability. Cannabis processes must consider biological and supplier variation.

Best-practice recommendations

• Create a CPV plan as part of the process validation lifecycle.
• Base CPV on CQAs, CPPs and process risk assessment.
• Define review frequency and responsibilities.
• Use simple visual trending before overcomplicating with advanced statistics.
• Review trends across batches, campaigns, products and time periods.
• Link CPV outcomes to deviations, CAPA, change control and PQR/APQR.
• Review the CPV plan when the process, equipment, specification or risk profile changes.
• Use CPV as a continuous-improvement tool, not only a compliance activity.

Frequently asked questions